Literature DB >> 7428708

Evidence for autoregulation of growth hormone secretion via the central nervous system.

G S Tannenbaum.   

Abstract

The ability of growth hormone (GH() to regulate its own secretion at the level of the central nervous system was examined in chronically cannulated freely-moving rats. Six-hour GH secretory profiles were obtained from 2 groups of rats administered either normal saline or rat GH via the lateral ventricle of the brain. The typical pulsatile pattern of GH secretion was evident in normal saline-treated control rats with most peak GH values > 400 ng/ml. Injection of rat GH (15 microgram/10 microliter) resulted in a significant suppression in amplitude of GH secretory pulses after an interval of 1 hour and plasma GH levels remained markedly depressed for up to 6 h after injection. Peak GH values did not exceed 76 ng/ml during the latter 3 h of the sampling period. These findings clearly demonstrate that GH can regulate its own secretion via a negative feedback system. Furthermore, the results suggest that the central nervous system is an important site of action for GH autoregulation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7428708     DOI: 10.1210/endo-107-6-2117

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

Review 1.  Thyroid hormones and growth hormone secretion.

Authors:  R Valcavi; M Zini; I Portioli
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

Review 2.  The role of growth factors in the pituitary.

Authors:  S Ezzat; S Melmed
Journal:  J Endocrinol Invest       Date:  1990-09       Impact factor: 4.256

Review 3.  Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2.

Authors:  J D Veldhuis; W S Evans; C Y Bowers; S Anderson
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

Review 4.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

5.  Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats.

Authors:  M C Ghigo; A Torsello; R Grilli; M Luoni; M Guidi; S G Cella; V Locatelli; E E Müller
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

6.  Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: II. A study in the infant rat.

Authors:  R Grilli; M C Ghigo; A Torsello; M Guidi; M Luoni; V Locatelli; E E Müller
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

7.  The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children.

Authors:  J Bellone; S Bellone; G Aimaretti; M R Valetto; C Baffoni; G Corneli; C Origlia; E Arvat; E Ghigo
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 4.256

8.  Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.

Authors:  C B Webb; M L Vance; M O Thorner; G Perisutti; J Thominet; J Rivier; W Vale; L A Frohman
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

9.  Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.

Authors:  M L Vance; D L Kaiser; W S Evans; R Furlanetto; W Vale; J Rivier; M O Thorner
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

10.  Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat.

Authors:  J Bertherat; J Timsit; M T Bluet-Pajot; J J Mercadier; D Gourdji; C Kordon; J Epelbaum
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.